Entero Therapeutics, Inc.(ENTO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ENTO Entero Therapeutics, Inc.

交易中 12-15 12:06:10 EST

2.99

+0.00

0.00%

最高2.99	最低2.99	成交量0.00
今开2.99	昨收2.99	日振幅0.00%
总市值1,005万	流通市值602.84万	总股本336.19万
成交额0.00	换手率0.00%	流通股本201.62万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ENTO","market":"US","secType":"STK","nameCN":"Entero Therapeutics, Inc.","latestPrice":2.99,"timestamp":1765818370024,"preClose":2.99,"halted":8,"volume":0,"delay":0,"floatShares":2016200,"shares":3361903,"eps":-18.094645,"marketStatus":"交易中","change":0,"latestTime":"12-15 12:06:10 EST","open":2.99,"high":2.99,"low":2.99,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.094645,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"symbolChange":{"newSymbol":"GRDX","executeDate":"2025-12-01"},"adr":0,"listingDate":1476158400000,"exchange":"NASDAQ","adjPreClose":2.99,"volumeRatio":0},"requestUrl":"/m/hq/s/ENTO/wiki","defaultTab":"wiki","newsList":[{"id":"1102633563","title":"Entero Therapeutics Inc于9月3日立即解除临时首席执行官兼董事长Richard Joel Paolone职务","url":"https://stock-news.laohu8.com/highlight/detail?id=1102633563","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102633563?lang=zh_cn&edition=full","pubTime":"2025-09-10 05:03","pubTimestamp":1757451812,"startTime":"0","endTime":"0","summary":"根据SEC文件显示，Entero Therapeutics Inc于9月3日宣布立即解除临时首席执行官兼董事长Richard Joel Paolone的职务。该决定即刻生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENTO","BK4139"],"gpt_icon":0},{"id":"2558697985","title":"Entero Therapeutics Inc.8月11日成交额为1.98亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558697985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558697985?lang=zh_cn&edition=full","pubTime":"2025-08-12 10:13","pubTimestamp":1754964797,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Entero Therapeutics Inc.成交额为1.98亿美元，成交额较昨日增加325996.83%，当日成交量为3.02亿股。Entero Therapeutics Inc.于2025年8月11日涨66.46%，报0.607美元，该股过去5个交易日涨42.92%，年初至今跌2.35%，过去60日涨45.31%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|1.98亿|325996.83%|3.02亿|#|2025-08-08|6.07万|-9.15%|16.12万|#|2025-08-07|6.68万|-57.85%|16.99万|#|2025-08-06|15.85万|1538.90%|36.07万|#|2025-08-05|9671.00|-41.14%|2.29万|Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非全身性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812101323a4830097&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812101323a4830097&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","ENTO","BK4139","LENZ"],"gpt_icon":0},{"id":"2555909666","title":"Entero Therapeutics Inc.7月29日成交额为5.71万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555909666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555909666?lang=zh_cn&edition=full","pubTime":"2025-07-30 10:09","pubTimestamp":1753841385,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Entero Therapeutics Inc.成交额为5.71万美元，成交额较昨日增加14.31%，当日成交量为11.86万股。Entero Therapeutics Inc.于2025年7月29日跌0.04%，报0.471美元，该股过去5个交易日跌4.83%，年初至今跌24.26%，过去60日涨32.7%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-29|5.71万|14.31%|11.86万|#|2025-07-28|5.00万|109.40%|10.22万|#|2025-07-25|2.39万|-62.82%|5.03万|#|2025-07-24|6.42万|285.03%|13.32万|#|2025-07-23|1.67万|-57.70%|3.35万|Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非全身性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730100947a6c8bea6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730100947a6c8bea6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2552415661","title":"Entero Therapeutics Inc.7月18日成交额为12.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552415661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552415661?lang=zh_cn&edition=full","pubTime":"2025-07-19 09:58","pubTimestamp":1752890292,"startTime":"0","endTime":"0","summary":"美东时间2025年7月18日，Entero Therapeutics Inc.成交额为12.23万美元，成交额较昨日减少28.06%，当日成交量为25.81万股。Entero Therapeutics Inc.于2025年7月18日跌0.08%，报0.473美元，该股过去5个交易日跌3.51%，年初至今跌23.99%，过去60日涨31.33%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-18|12.23万|-28.06%|25.81万|#|2025-07-17|17.00万|231.52%|36.55万|#|2025-07-16|5.13万|-45.27%|11.25万|#|2025-07-15|9.37万|-44.48%|20.65万|#|2025-07-14|16.87万|24.19%|35.85万|Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非全身性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719095813a4548d79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719095813a4548d79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2518224070","title":"Entero Therapeutics Inc.盘中异动 早盘股价大跌7.38%报0.510美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518224070?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:34","pubTimestamp":1741613681,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时34分，Entero Therapeutics Inc.股票出现波动，股价大幅跳水7.38%。截至发稿，该股报0.510美元/股，成交量2346股，换手率0.05%，振幅0.00%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021344198a29d98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021344198a29d98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ENTO"],"gpt_icon":0},{"id":"2517943330","title":"Entero Therapeutics Inc.盘中异动 股价大跌5.68%报0.480美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517943330?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185059,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Entero Therapeutics Inc.股票出现波动，股价急速下挫5.68%。截至发稿，该股报0.480美元/股，成交量1.0517万股，换手率0.22%，振幅0.00%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223059abe9b061&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223059abe9b061&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","LENZ","BK4139"],"gpt_icon":0},{"id":"2516634439","title":"Entero Therapeutics Inc.盘中异动 急速拉升27.79%报0.632美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634439?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012344,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，Entero Therapeutics Inc.股票出现波动，股价快速上涨27.79%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.26%、26.54%、22.55%，振幅较大的相关个股有Entero Therapeutics Inc.、Cibus, Inc.、Galmed Pharmaceuticals Ltd.，振幅分别为21.22%、9.55%、9.35%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223224a25d3ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223224a25d3ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","LENZ","BK4139"],"gpt_icon":0},{"id":"2514838611","title":"Entero Therapeutics Inc.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514838611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514838611?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:53","pubTimestamp":1740667981,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时53分，Entero Therapeutics Inc.股票出现异动，股价大幅拉升5.24%。截至发稿，该股报0.500美元/股，成交量917股，换手率0.02%，振幅5.24%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225301abdf742c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225301abdf742c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","LENZ","BK4139"],"gpt_icon":0},{"id":"2511529355","title":"Entero Therapeutics Inc.盘中异动 早盘急速拉升5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511529355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511529355?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:02","pubTimestamp":1739458923,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时02分，Entero Therapeutics Inc.股票出现波动，股价大幅拉升5.69%。截至发稿，该股报0.520美元/股，成交量1326股，换手率0.03%，振幅0.02%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230203a244b2b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213230203a244b2b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","BK4139","LENZ"],"gpt_icon":0},{"id":"2510864800","title":"Entero Therapeutics Inc.盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510864800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510864800?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:29","pubTimestamp":1739201344,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时29分，Entero Therapeutics Inc.股票出现异动，股价急速下挫5.44%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2546.81%、1506.45%、953.64%，振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Immatics N V C/Wts 01/07/2025 ，振幅分别为69.83%、66.09%、50.50%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102329049880845b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102329049880845b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTO","LENZ"],"gpt_icon":0},{"id":"2509096742","title":"Entero Therapeutics Inc.盘中异动 快速拉升5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509096742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509096742?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:52","pubTimestamp":1738939930,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时52分，Entero Therapeutics Inc.股票出现异动，股价大幅拉升5.94%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2806.96%、63.59%、62.78%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、60.00%、31.94%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225210abc62f54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225210abc62f54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","LENZ","BK4139"],"gpt_icon":0},{"id":"2509585662","title":"Entero Therapeutics Inc.盘中异动 股价大涨9.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509585662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509585662?lang=zh_cn&edition=full","pubTime":"2025-02-06 02:53","pubTimestamp":1738781611,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日02时53分，Entero Therapeutics Inc.股票出现波动，股价急速上涨9.20%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为2.22%。其相关个股中，Transcode Therapeutics, Inc.、Invivyd, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4599.67%、2322.56%、1735.78%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.，振幅分别为132.24%、99.51%、67.19%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206025331a23ab1e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206025331a23ab1e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ENTO"],"gpt_icon":0},{"id":"2508125989","title":"Entero Therapeutics Inc.盘中异动 股价大涨8.37%报0.540美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508125989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508125989?lang=zh_cn&edition=full","pubTime":"2025-02-04 01:10","pubTimestamp":1738602648,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日01时10分，Entero Therapeutics Inc.股票出现异动，股价快速拉升8.37%。截至发稿，该股报0.540美元/股，成交量2.1576万股，换手率0.45%，振幅7.97%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204011048a2382927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204011048a2382927&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","BK4139","LENZ"],"gpt_icon":0},{"id":"2507961875","title":"Entero Therapeutics Inc.盘中异动 早盘股价大涨6.02%报0.530美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507961875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507961875?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:31","pubTimestamp":1738333862,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时31分，Entero Therapeutics Inc.股票出现异动，股价大幅上涨6.02%。截至发稿，该股报0.530美元/股，成交量1.1181万股，换手率0.24%，振幅0.00%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223102a23541c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223102a23541c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","BK4139","LENZ"],"gpt_icon":0},{"id":"2506276306","title":"Entero Therapeutics Inc.盘中异动 大幅上涨6.40%报0.532美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506276306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506276306?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:14","pubTimestamp":1737990851,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时14分，Entero Therapeutics Inc.股票出现异动，股价急速拉升6.40%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1711.94%、188.55%、164.22%，振幅较大的相关个股有阿诺医药、Onconetix, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为98.54%、85.35%、61.25%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012723141296124078&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012723141296124078&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","LENZ","BK4139"],"gpt_icon":0},{"id":"2505375861","title":"Entero Therapeutics Inc.盘中异动 股价大涨7.33%报0.538美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505375861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505375861?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:53","pubTimestamp":1737730383,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时53分，Entero Therapeutics Inc.股票出现异动，股价快速上涨7.33%。截至发稿，该股报0.538美元/股，成交量2442股，换手率0.05%，振幅9.42%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124225303a22e5f3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124225303a22e5f3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ENTO","BK4139"],"gpt_icon":0},{"id":"2505721847","title":"Entero Therapeutics Inc.股价重挫10.26% 市值跌23.9万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505721847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505721847?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:45","pubTimestamp":1737557103,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时45分，Entero Therapeutics Inc.股票出现异动，股价急速跳水10.26%。截至发稿，该股报0.490美元/股，成交量2090股，换手率0.04%，振幅0.00%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122224503a22bb4c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122224503a22bb4c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","BK4139","LENZ"],"gpt_icon":0},{"id":"2505272357","title":"Entero Therapeutics Inc.盘中异动 早盘股价大涨5.56%报0.570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505272357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505272357?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:34","pubTimestamp":1737470087,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时34分，Entero Therapeutics Inc.股票出现波动，股价急速拉升5.56%。截至发稿，该股报0.570美元/股，成交量2358股，换手率0.05%，振幅3.70%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223447960bb9b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223447960bb9b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","BK4139","LENZ"],"gpt_icon":0},{"id":"2504196804","title":"Entero Therapeutics Inc.盘中异动 早盘股价大涨9.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504196804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504196804?lang=zh_cn&edition=full","pubTime":"2025-01-18 00:29","pubTimestamp":1737131354,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日00时29分，Entero Therapeutics Inc.股票出现异动，股价大幅拉升9.07%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180029149607b2f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501180029149607b2f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","BK4139","LENZ"],"gpt_icon":0},{"id":"2503915192","title":"Entero Therapeutics Inc.盘中异动 早盘股价大跌7.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503915192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503915192?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:33","pubTimestamp":1737037992,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时33分，Entero Therapeutics Inc.股票出现波动，股价急速下挫7.44%。截至发稿，该股报0.520美元/股，成交量9505股，换手率0.20%，振幅7.08%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223312a2245feb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116223312a2245feb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.enterothera.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.2234},{"period":"3month","weight":-0.0508},{"period":"6month","weight":1.0328},{"period":"1year","weight":0.5903},{"period":"ytd","weight":0.6024}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Entero Therapeutics, Inc.在美国特拉华州成立于2014年1月30日。该公司是一家临床阶段的生物制药公司，从事的是为胃肠功能紊乱患者的治疗，研究和开发非系统性生物制剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.100501},{"month":2,"riseRate":0.111111,"avgChangeRate":-0.047532},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.098336},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.145731},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.072831},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.094933},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.226619},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.05499},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.070567},{"month":10,"riseRate":0.333333,"avgChangeRate":0.014204},{"month":11,"riseRate":0.3,"avgChangeRate":-0.121901},{"month":12,"riseRate":0.666667,"avgChangeRate":0.05658}],"exchange":"NASDAQ","name":"Entero Therapeutics, Inc.","nameEN":"Entero Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Entero Therapeutics, Inc.(ENTO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Entero Therapeutics, Inc.(ENTO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Entero Therapeutics, Inc.,ENTO,Entero Therapeutics, Inc.股票,Entero Therapeutics, Inc.股票老虎,Entero Therapeutics, Inc.股票老虎国际,Entero Therapeutics, Inc.行情,Entero Therapeutics, Inc.股票行情,Entero Therapeutics, Inc.股价,Entero Therapeutics, Inc.股市,Entero Therapeutics, Inc.股票价格,Entero Therapeutics, Inc.股票交易,Entero Therapeutics, Inc.股票购买,Entero Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Entero Therapeutics, Inc.(ENTO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Entero Therapeutics, Inc.(ENTO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}